In the last trading session, 1.66 million shares of the Pasithea Therapeutics Corp (NASDAQ:KTTA) were traded, and its beta was 0.37. Most recently the company’s share price was $1.42, and it changed around -$0.18 or -11.25% from the last close, which brings the market valuation of the company to $3.85M. KTTA currently trades at a discount to its 52-week high of $8.11, offering almost -471.13% off that amount. The share price’s 52-week low was $0.92, which indicates that the current value has risen by an impressive 35.21% since then. We note from Pasithea Therapeutics Corp’s average daily trading volume that its 10-day average is 10.37 million shares, with the 3-month average coming to 2.73 million.
Pasithea Therapeutics Corp stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended KTTA as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Pasithea Therapeutics Corp is expected to report earnings per share of 0 for the current quarter.
Pasithea Therapeutics Corp (NASDAQ:KTTA) trade information
Instantly KTTA has showed a red trend with a performance of -11.25% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.3400 on recent trading dayincreased the stock’s daily price by 39.32%. The company’s shares are currently down -54.92% year-to-date, but still up 11.81% over the last five days. On the other hand, Pasithea Therapeutics Corp (NASDAQ:KTTA) is 36.54% up in the 30-day period. We can see from the shorts that 14425.0 shares have been sold at a short interest cover period of 0.18 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -282.28%.
KTTA Dividends
Pasithea Therapeutics Corp’s next quarterly earnings report is expected to be released on 2022-May-15.
Pasithea Therapeutics Corp (NASDAQ:KTTA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 8.93% of Pasithea Therapeutics Corp shares, and 4.65% of them are in the hands of institutional investors. The stock currently has a share float of 5.10%.
AdvisorShares Trust-AdvisorShares Psychedelics ETF and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 53.55 shares worth $76036.0, making up 1.98% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held roughly 2.96 shares worth around $4208.0, which represents about 0.11% of the total shares outstanding.
